• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

球形核酸纳米粒子:治疗潜力。

Spherical Nucleic Acid Nanoparticles: Therapeutic Potential.

机构信息

Biomedical Engineering, University of Delaware, Newark, DE, 19716, USA.

Materials Science and Engineering, University of Delaware, Newark, DE, 19716, USA.

出版信息

BioDrugs. 2018 Aug;32(4):297-309. doi: 10.1007/s40259-018-0290-5.

DOI:10.1007/s40259-018-0290-5
PMID:29959665
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6428072/
Abstract

Spherical nucleic acids (SNAs) are highly oriented, well organized, polyvalent structures of nucleic acids conjugated to hollow or solid core nanoparticles. Because they can transfect many tissue and cell types without toxicity, induce minimum immune response, and penetrate various biological barriers (such as the skin, blood-brain barrier, and blood-tumor barrier), they have become versatile tools for the delivery of nucleic acids, drugs, and proteins for various therapeutic purposes. This article describes the unique structures and properties of SNAs and discusses how these properties enable their application in gene regulation, immunomodulation, and drug and protein delivery. It also summarizes current efforts towards clinical translation of SNAs and provides an expert opinion on remaining challenges to be addressed in the path forward to the clinic.

摘要

球形核酸(SNAs)是一种高度定向、组织良好、多价的核酸结构,与中空或实心核纳米颗粒相连。由于它们可以转染多种组织和细胞类型而没有毒性,诱导最小的免疫反应,并穿透各种生物屏障(如皮肤、血脑屏障和血肿瘤屏障),因此它们已成为用于各种治疗目的的核酸、药物和蛋白质传递的多功能工具。本文描述了 SNAs 的独特结构和特性,并讨论了这些特性如何使其能够应用于基因调控、免疫调节以及药物和蛋白质的传递。它还总结了目前将 SNAs 推向临床应用的努力,并就未来临床应用中需要解决的挑战提供了专家意见。

相似文献

1
Spherical Nucleic Acid Nanoparticles: Therapeutic Potential.球形核酸纳米粒子:治疗潜力。
BioDrugs. 2018 Aug;32(4):297-309. doi: 10.1007/s40259-018-0290-5.
2
Applications of Spherical Nucleic Acid Nanoparticles as Delivery Systems.球形核酸纳米粒子作为递药系统的应用。
Trends Mol Med. 2019 Dec;25(12):1066-1079. doi: 10.1016/j.molmed.2019.08.012. Epub 2019 Nov 6.
3
Recent advances in gene delivery nanoplatforms based on spherical nucleic acids.基于球形核酸的基因递纳米平台的最新进展。
J Nanobiotechnology. 2024 Jul 1;22(1):386. doi: 10.1186/s12951-024-02648-5.
4
Spherical nucleic acid nanoparticle conjugates as an RNAi-based therapy for glioblastoma.球形核酸纳米颗粒缀合物作为胶质母细胞瘤的 RNAi 治疗方法。
Sci Transl Med. 2013 Oct 30;5(209):209ra152. doi: 10.1126/scitranslmed.3006839.
5
Synthesis, Physicochemical, and Biological Evaluation of Spherical Nucleic Acids for RNAi-Based Therapy in Glioblastoma.用于胶质母细胞瘤基于RNA干扰疗法的球形核酸的合成、物理化学及生物学评价
Methods Mol Biol. 2019;1974:371-391. doi: 10.1007/978-1-4939-9220-1_25.
6
Therapeutic applications of spherical nucleic acids.球形核酸的治疗应用。
Cancer Treat Res. 2015;166:23-50. doi: 10.1007/978-3-319-16555-4_2.
7
Spherical nucleic acids: emerging amplifiers for therapeutic nanoplatforms.球形核酸:治疗性纳米平台的新兴扩增子。
Nanoscale. 2024 Feb 29;16(9):4392-4406. doi: 10.1039/d3nr05971e.
8
Cancer-Targeting Nanoparticles for Combinatorial Nucleic Acid Delivery.用于组合核酸递送的癌症靶向纳米颗粒。
Adv Mater. 2020 Apr;32(13):e1901081. doi: 10.1002/adma.201901081. Epub 2019 Jun 20.
9
A first-in-human phase 0 clinical study of RNA interference-based spherical nucleic acids in patients with recurrent glioblastoma.在复发性胶质母细胞瘤患者中进行基于 RNA 干扰的球形核酸的首次人体 0 期临床研究。
Sci Transl Med. 2021 Mar 10;13(584). doi: 10.1126/scitranslmed.abb3945.
10
Peptides for nucleic acid delivery.用于核酸递送的肽。
Adv Drug Deliv Rev. 2016 Nov 15;106(Pt A):172-182. doi: 10.1016/j.addr.2016.06.008. Epub 2016 Jun 25.

引用本文的文献

1
New Approach to Assembling Nucleic Acid Dendrons on a Solid Phase.在固相上组装核酸树枝状分子的新方法。
Org Lett. 2025 Aug 29;27(34):9500-9505. doi: 10.1021/acs.orglett.5c02877. Epub 2025 Aug 20.
2
Nucleic Acid-Modified Nanoparticles for Cancer Therapeutic Applications.用于癌症治疗应用的核酸修饰纳米颗粒
Small. 2025 Jul;21(27):e2500843. doi: 10.1002/smll.202500843. Epub 2025 May 27.
3
Simultaneous Targeting of Tumor Cells and Tumor-Associated Macrophages To Reprogram Glioblastoma Using Trypsinized Extracellular Vesicles Carrying Tumor Suppressive MicroRNA.

本文引用的文献

1
Nanoparticle-Mediated Gene Regulation as a Novel Strategy for Cancer Therapy.纳米颗粒介导的基因调控作为一种癌症治疗的新策略。
Dela J Public Health. 2017 Jun 29;3(3):20-24. doi: 10.32481/djph.2017.06.006. eCollection 2017 Jun.
2
Intradermal immunisation using the TLR3-ligand Poly (I:C) as adjuvant induces mucosal antibody responses and protects against genital HSV-2 infection.使用Toll样受体3(TLR3)配体聚肌苷酸胞苷酸(Poly (I:C))作为佐剂进行皮内免疫可诱导黏膜抗体反应,并预防生殖器单纯疱疹病毒2型(HSV-2)感染。
NPJ Vaccines. 2016 Aug 25;1:16010. doi: 10.1038/npjvaccines.2016.10. eCollection 2016.
3
Extending antigen release from particulate vaccines results in enhanced antitumor immune response.
利用携带肿瘤抑制性微小RNA的胰蛋白酶处理的细胞外囊泡同时靶向肿瘤细胞和肿瘤相关巨噬细胞以重编程胶质母细胞瘤
Nano Lett. 2025 May 21;25(20):8414-8422. doi: 10.1021/acs.nanolett.5c01897. Epub 2025 May 13.
4
Suppressed activation of the IRF7 and TLR9 by JAK2V617F gold nanoparticles.JAK2V617F金纳米颗粒抑制IRF7和TLR9的激活。
Immunogenetics. 2025 Feb 28;77(1):16. doi: 10.1007/s00251-025-01374-y.
5
Photochemical Stabilization of Self-Assembled Spherical Nucleic Acids.自组装球形核酸的光化学稳定化
Small. 2025 Feb;21(7):e2407742. doi: 10.1002/smll.202407742. Epub 2025 Jan 10.
6
DENV Peptides Delivered as Spherical Nucleic Acid Constructs Enhance Antigen Presentation and Immunogenicity in vitro and in vivo.球形核酸构建体递呈登革病毒肽增强体外和体内的抗原呈递和免疫原性。
Int J Nanomedicine. 2024 Sep 20;19:9757-9770. doi: 10.2147/IJN.S467427. eCollection 2024.
7
Antibody and siRNA Nanocarriers to Suppress Wnt Signaling, Tumor Growth, and Lung Metastasis in Triple-Negative Breast Cancer.用于抑制三阴性乳腺癌中Wnt信号传导、肿瘤生长和肺转移的抗体和小干扰RNA纳米载体
Adv Ther (Weinh). 2024 Jun;7(6). doi: 10.1002/adtp.202300426. Epub 2024 Apr 26.
8
Recent advances in gene delivery nanoplatforms based on spherical nucleic acids.基于球形核酸的基因递纳米平台的最新进展。
J Nanobiotechnology. 2024 Jul 1;22(1):386. doi: 10.1186/s12951-024-02648-5.
9
Life at the interface: Engineering bio-nanomaterials through interfacial molecular self-assembly.界面上的生命:通过界面分子自组装工程生物纳米材料。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2024 May-Jun;16(3):e1966. doi: 10.1002/wnan.1966.
10
Improving DNA nanostructure stability: A review of the biomedical applications and approaches.提高 DNA 纳米结构稳定性:生物医学应用和方法综述。
Int J Biol Macromol. 2024 Mar;260(Pt 1):129495. doi: 10.1016/j.ijbiomac.2024.129495. Epub 2024 Jan 14.
延长微粒状疫苗的抗原释放可增强抗肿瘤免疫应答。
J Control Release. 2018 Jan 10;269:393-404. doi: 10.1016/j.jconrel.2017.11.020. Epub 2017 Nov 13.
4
Using siRNA-based spherical nucleic acid nanoparticle conjugates for gene regulation in psoriasis.利用基于 siRNA 的球形核酸纳米粒子缀合物调节银屑病中的基因。
J Control Release. 2017 Dec 28;268:259-268. doi: 10.1016/j.jconrel.2017.10.034. Epub 2017 Oct 23.
5
Precision spherical nucleic acids for delivery of anticancer drugs.用于递送抗癌药物的精准球形核酸
Chem Sci. 2017 Sep 1;8(9):6218-6229. doi: 10.1039/c7sc01619k. Epub 2017 Jul 5.
6
Topically Delivered Tumor Necrosis Factor-α-Targeted Gene Regulation for Psoriasis.局部递送肿瘤坏死因子-α靶向基因调控治疗银屑病
J Invest Dermatol. 2017 Sep;137(9):2027-2030. doi: 10.1016/j.jid.2017.04.027. Epub 2017 May 11.
7
Dual bioluminescence and near-infrared fluorescence monitoring to evaluate spherical nucleic acid nanoconjugate activity in vivo.双荧光素酶和近红外荧光监测评估体内球形核酸纳米复合物的活性。
Proc Natl Acad Sci U S A. 2017 Apr 18;114(16):4129-4134. doi: 10.1073/pnas.1702736114. Epub 2017 Apr 3.
8
FDA-Approved Oligonucleotide Therapies in 2017.2017年美国食品药品监督管理局批准的寡核苷酸疗法
Mol Ther. 2017 May 3;25(5):1069-1075. doi: 10.1016/j.ymthe.2017.03.023. Epub 2017 Mar 31.
9
Enzyme-Cleavable Polymeric Micelles for the Intracellular Delivery of Proapoptotic Peptides.用于细胞内递送促凋亡肽的酶可裂解聚合物胶束
Mol Pharm. 2017 May 1;14(5):1450-1459. doi: 10.1021/acs.molpharmaceut.6b01178. Epub 2017 Mar 30.
10
Cross-Linked Micellar Spherical Nucleic Acids from Thermoresponsive Templates.基于温敏模板的交联胶束球形核酸
J Am Chem Soc. 2017 Mar 29;139(12):4278-4281. doi: 10.1021/jacs.6b13359. Epub 2017 Mar 20.